| Delaware (State or other jurisdiction of incorporation or organization) | | | 82-4592913 (I.R.S. Employer Identification Number) | |
| Jack S. Bodner Covington & Burling LLP | | | Elizabeth M. Keiley General Counsel Entasis Therapeutics Holdings Inc. 35 Gatehouse Drive Waltham, Massachusetts 02451 (781) 810-0120 | |
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☒ | | | Smaller reporting company ☒ Emerging growth company ☒ | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Title of Each Class of Securities to be Registered | | | | Amount to be Registered(1) | | | | Proposed Maximum Offering Price per Unit(2) | | | | Proposed Maximum Aggregate Offering Price(2) | | | | Amount of Registration Fee | | | | | Amount to be Registered(1) | | | | Proposed Maximum Offering Price per Unit(2) | | | | Proposed Maximum Aggregate Offering Price(2) | | | | Amount of Registration Fee | | ||||||||||||||||||||||||
Common Stock, par value $0.001 per share | | | | | | 18,691,588 | | | | | | $ | 2.05 | | | | | | $ | 38,317,755.40 | | | | | | $ | 4,180.47 | | | | | | | | 20,000,000 | | | | | | $ | 2.35 | | | | | | $ | 47,043,000.00 | | | | | | $ | 5,132.40 | | |
Warrants to Purchase Common Stock(3) | | | | | | 10,507,710 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | | 10,000,000 | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | | | | | | ||
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 5 | | | |
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | |
| | | Before Offering | | | After Offering | | ||||||||||||||||||
Name and Address of Selling Stockholder | | | Number of Shares of Common Stock Beneficially Owned (1) | | | Number of Shares of Common Stock Offered | | | Number of Shares of Common Stock Beneficially Owned | | | Percentage of Shares of Common Stock Beneficially Owned | | ||||||||||||
Innoviva | | | | | | | | | | ||||||||||||||||
| | | | | — | | | | | | — | | |
Expense | | Amount | | | Amount | | ||||||||
SEC Registration Fee | | | $ | 4,180.47 | | | | | $ | 5,132.40 | | | ||
Accounting Fees and Expenses | | | $ | 10,000.00 | | | | | $ | 10,000 | | | ||
Legal Fees and Expenses | | | $ | 25,000.00 | | | | | $ | 25,000 | | | ||
Miscellaneous | | | | — | | | | | $ | — | | | ||
Total | | | $ | 39,180.47 | | | | | $ | 40,132.40 | | |
ENTASIS THERAPEUTICS HOLDINGS INC. By: /s/ MANOUSSOS PERROS Manoussos Perros, Ph.D. President and Chief Executive Officer | ||||||||
| Signature | | | Title | | | Date | |
| /s/ MANOUSSOS PERROS Manoussos Perros, Ph.D. | | | President, Chief Executive Officer and Director (Principal Executive Officer) | | | | |
| /s/ MICHAEL GUTCH Michael Gutch, Ph.D. | | | Chief Business Officer and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | | | | |
| /s/ DAVID MEEK David Meek | | | Chairman of the Board of Directors | | | | |
| /s/ HEATHER BEHANNA Heather Behanna, Ph.D. | | | Director | | | | |
| /s/ DAVID C. HASTINGS David C. Hastings | | | Director | | | | |
| /s/ HOWARD MAYER Howard Mayer, M.D. | | | Director | | | | |
| /s/ HEATHER PRESTON Heather Preston, M.D. | | | Director | | | |